Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nintedanib and Cyclophosphamide in Advanced Ovarian Cancer
NCT01610869Phase 2Completed
- Sponsor
- University College London
- Start
- Aug 2014
- Primary completion
- Jan 2018
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of nintedanib in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal carcinoma (PPC), sponsored by University College London. Started Aug 2014; status: completed.
02
Drugs
nintedanib
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal carcinoma (PPC)
Beyond the preview
Go deeper on NCT01610869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01610869.